Detailed isoform-specific functional investigations demonstrated that both DCLK1-L variants trigger cancer stemness and EMT activation and mediate hypoxia-PLOD2-induced malignant properties in ccRCC. The gene discussed is PLOD2; the disease is nonpapillary renal cell carcinoma.